Vincent Ma, MD, discusses the next steps in proving the value of circulating tumor DNA in predicting outcomes of advanced ...

Similar to brachytherapy, OncoPatch could be an option for patients who have superficial lesions or who aren’t surgical candidates.

Appropriate use of immune checkpoint inhibitors and immunotherapy differs in adults with unresectable, metastatic cutaneous ...

Self-examination behavior varied markedly: roughly 20% reported none in the prior year, while about one-third examined weekly or monthly despite >90% rating checks as important. Nearly half of trial ...

Health Notes is an occasional listing of health happenings around Louisiana. Have something you'd like to share? Contact us at margaret.delaney@theadvocate.com.

In an interview, Vincent Ma, MD, discussed how ctDNA levels after the first cycle of immune checkpoint inhibitor in melanoma ...

In this study, researchers aimed to fill gaps in the knowledge of treatment management and outcomes in melanoma patients aged 75 years and older.

We are curing more cancers than we used to,” Cottrill said. “Recurrent cancers are more challenging to cure than cancers that ...

Skin cancer is the most common cancer in the United States, but doctors say many cases are preventable through protective ...

Registration link below for Wednesday March 18, 2026 at 4 PM EDT Phio invites individual and institutional investors, as well ...

Ipilimumab-nivolumab also linked with better survival but more toxicity in small study ...

Immunocore will present five-year overall survival data for KIMMTRAK during oral presentation at the 2026 AACR meeting ...